Effects of Parenteral Hydration in Terminally Ill Cancer Patients: A Preliminary Study
- 1 April 2005
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (10), 2366-2371
- https://doi.org/10.1200/jco.2005.04.069
Abstract
Purpose Most patients with cancer develop decreased oral intake and dehydration before death. This study aimed to determine the effect of parenteral hydration on overall symptom control in terminally ill cancer patients with dehydration. Patients and Methods Patients with clinical evidence of mild to moderate dehydration and a liquid oral intake less than 1,000 mL/day were randomly assigned to receive either parenteral hydration with 1,000 mL (treatment group) or placebo with 100 mL normal saline administered over 4 hours for 2 days. Patients were evaluated for target symptoms (hallucinations, myoclonus, fatigue, and sedation), global well-being, and overall benefit. Results Twenty-seven patients randomly assigned to the treatment group had improvement in 53 (73%) of their 73 target symptoms versus 33 (49%) of 67 target symptoms in the placebo group (n=22; P = .005). Fifteen (83%) of 18 and 15 (83%) of 18 patients had improved myoclonus and sedation after hydration versus eight (47%) of 17 and five (33%) of 15 patients after placebo (P = .035 and P = .005, respectively). There were no significant differences of improvement in hallucinations or fatigue between groups. When blinded to treatment, patients (17 [63%] of 77) and investigators (20 [74%] of 27) perceived hydration as effective compared with placebo in nine (41%) of 22 patients (P = .78) and 12 (54%) of 22 investigators (P = .15), respectively. The intensity of pain and swelling at the injection site were not significantly different between groups. Conclusion Parenteral hydration decreased symptoms of dehydration in terminally ill cancer patients who had decreased fluid intake. Hydration was well tolerated, and a placebo effect was observed. Studies with larger samples and a longer follow-up period are justified.Keywords
This publication has 22 references indexed in Scilit:
- To Hydrate or Not to Hydrate: How Should It Be?Journal of Clinical Oncology, 2000
- Opioid rotation for toxicity reduction in terminal cancer patientsJournal of Pain and Symptom Management, 1995
- Rehydration in palliative and terminal care: if not- why not?Palliative Medicine, 1995
- On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far? A reply.Journal of Medical Ethics, 1995
- Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration, and opioid rotationJournal of Pain and Symptom Management, 1995
- The use of hypodermoclysis for rehydration in terminally ill cancer patientsJournal of Pain and Symptom Management, 1994
- Cognitive failure in patients with terminal cancer: A prospective studyJournal of Pain and Symptom Management, 1992
- Character of terminal illness in the advanced cancer patient: Pain and other symptoms during the last four weeks of lifeJournal of Pain and Symptom Management, 1990
- Use of the subcutaneous route for the administration of narcotics in patients with cancer painCancer, 1988
- Comfort Measures for the Terminally IIIJournal of the American Geriatrics Society, 1985